India has enhanced its Hantavirus surveillance measures through the nationwide Viral Research and Diagnostic Laboratory Network to counter potential zoonotic threats. Operating under the Indian Council of Medical Research and the National Institute of Virology, this network comprises 165 specialized laboratories equipped with reverse transcription polymerase chain reaction technology. The proactive mechanism monitors high-risk individuals, including patients presenting with severe respiratory symptoms and a history of recent international travel. As of May 2026, two asymptomatic Indian nationals aboard a cruise ship are under official observation. The World Health Organization has assessed the global public health risk of this current Hantavirus cluster as low, and there is no evidence of community transmission within India.
Virology and Taxonomy of Hantaviruses
Hantaviruses belong to the family Hantaviridae within the order Bunyavirales. These are enveloped, single-stranded, negative-sense RNA viruses. Unlike most other bunyaviruses, which are arboviruses transmitted by arthropod vectors like mosquitoes or ticks, hantaviruses are strictly zoonotic and rely on specific small mammal reservoirs.
Genomic Structure
The viral genome consists of three distinct segments:
- Large (L) Segment: Encodes the viral RNA-dependent RNA polymerase required for replication.
- Medium (M) Segment: Encodes the envelope glycoproteins (Gn and Gc) that facilitate host cell entry.
- Small (S) Segment: Encodes the nucleocapsid protein that encapsidates the viral RNA.
Clinical Syndromes and Manifestations
Hantavirus infections in humans result in two primary clinical syndromes depending on the geographic lineage of the viral strain.
| Clinical Syndrome | Primary Geographic Regions | Key Pathological Impact | Mortality Rate | Associated Viral Strains |
| Hantavirus Pulmonary Syndrome (HPS) / Hantavirus Cardiopulmonary Syndrome (HCPS) | Western Hemisphere (The Americas) | Severe respiratory distress, pulmonary edema, myocardial depression, and shock. | Up to 38% – 50% | Sin Nombre virus, Andes virus |
| Hemorrhagic Fever with Renal Syndrome (HFRS) | Eastern Hemisphere (Europe and Asia) | Vascular leakage, bleeding disorders, acute shock, and acute kidney failure. | 1% – 15% | Hantaan virus, Seoul virus, Dobrava virus, Puumala virus |
Incubation and Early Symptoms
The incubation period ranges from one to eight weeks post-exposure. Early clinical features are non-specific, mimicking influenza, and include:
- High fever and chills
- Severe myalgia (especially in the thighs, hips, and back)
- Gastrointestinal distress (abdominal pain, nausea, and vomiting)
Transmission Reservoirs and Pathways
Rodents, insectivores, and bats serve as the natural reservoir hosts. The animals remain chronically and asymptomatically infected, shedding the virus throughout their lives.
Mode of Exposure
- Inhalation of Aerosols: The primary route of human infection is inhaling micro-particles of dried rodent excreta (urine, feces, or saliva) suspended in the air. This frequently happens during activities like cleaning poorly ventilated spaces, farming, or forestry work.
- Direct Contact: Handling infected rodents or introducing contaminated materials into broken skin or mucous membranes.
- Rodent Bites: Less common but viable path of direct inoculation.
Human-to-Human Transmission
The Andes virus, native to South America (primarily Argentina and Chile), is the only known hantavirus capable of inter-human transmission. This pathway is rare and requires prolonged, close personal contact, usually occurring within households or enclosed cruise ship settings.
Diagnostic and Surveillance Infrastructure in India
Early diagnosis within the first 72 hours of symptom onset is challenging due to the overlapping nature of early febrile symptoms. India utilizes a multi-tiered laboratory strategy for confirmation.
Molecular and Serological Testing
- Reverse Transcription Polymerase Chain Reaction (RT-PCR): Used to detect viral RNA in clinical specimens during the early viremic phase.
- Serological Assays: Enzyme-Linked Immunosorbent Assay (ELISA) to identify hantavirus-specific IgM and IgG antibodies.
Institutional Framework
The Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), Pune, spearhead the diagnostic protocols. The 165-laboratory strong Viral Research and Diagnostic Laboratory (VRDL) network ensures decentralized capability for rapid containment and biological surveillance across various states.
Prevention, Management, and Control
No specific antiviral treatment or targeted vaccine is globally approved for hantavirus infections. Management relies entirely on early supportive care.
Medical Management
- For HPS/HCPS: Intensive care monitoring, mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) to manage severe respiratory failure.
- For HFRS: Fluid management, dialysis to mitigate acute kidney injury, and blood pressure regulation.
Vector and Environmental Control
Preventative strategies focus on breaking the rodent-to-human interface:
- Sealing entry points in residential and commercial buildings to prevent rodent colonization.
- Disinfecting rodent-contaminated areas with wet mops and liquid disinfectants instead of dry sweeping to prevent virus aerosolization.
- Maintaining strict hand hygiene and secure food storage.
IASPOINT Booster Facts for UPSC
- Thottapalayam Virus: This is an indigenous hantavirus strain first isolated from the Asian house shrew (Suncus murinus) in Tamil Nadu, India. It signifies that non-rodent small mammals also act as hantavirus reservoirs in the Indian subcontinent.
- Historical Context: The genus name is derived from the Hantan River in South Korea, where the Hantaan virus was first isolated by Dr. Ho Wang Lee in the late 1970s following a large outbreak among soldiers during the Korean War.
- One Health Approach: Hantavirus management fits into the “One Health” framework promoted by India, which integrates human health, animal health, and environmental management to counter zoonotic spillovers.
- Biosafety Classification: Due to high mortality rates and the lack of specific therapeutics, several hantaviruses are categorized as high-consequence pathogens requiring Biosafety Level 3 (BSL-3) or Biosafety Level 4 (BSL-4) containment facilities for handling.